Stock listing
NASDAQ:KNTE Kinnate Biopharma Inc Stock
Follow Kinnate Biopharma Inc into a list and get an email when it puts out news.
Last close · NASDAQ:KNTE
$2.65 USD
Close on Apr 3, 2024 · No longer trades
- Lowest – highest close
- $1.07 – $45.25 USDSince Dec 3, 2020 · lowest Oct 25, 2023 · highest Dec 9, 2020
Delisted NASDAQ:KNTE no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:KNTE
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dean Mitchell Other companies: Praxis Precision Medicines, Inc. (Chairman of the Board · Since at least Oct 15, 2020); Theravance Biopharma, Inc. (Director · Since at least Apr 30, 2019); Precigen, Inc. (Director · Mar 8, 2020 – Mar 14, 2024 · Past); ImmunoGen Inc (Director · Mar 31, 2019 – Feb 12, 2024 · Past) | Director · Dec 2, 2020 – Apr 3, 2024 · Past |
| Melissa Epperly Other companies: Roivant Sciences Ltd. (Director · Since at least Jun 29, 2022); Nautilus Biotechnology, Inc. (Director · Since at least Jun 9, 2021); Zentalis Pharmaceuticals, Inc. (Chief Financial Officer · Apr 3, 2020 – Feb 12, 2024 · Past) | Director · Dec 2, 2020 – Apr 3, 2024 · Past |
| Neha Krishnamohan Other companies: Latigo Biotherapeutics, Inc. (Chief Financial Officer and Chief Business Officer · Since at least Aug 6, 2026); Artiva Biotherapeutics, Inc. (Chief Financial Officer · Since at least Jul 18, 2024); Arcutis Biotherapeutics, Inc. (Director · Since at least Sep 2, 2022) | CHIEF FINANCIAL OFFICER · Jun 7, 2021 – Apr 3, 2024 · Past |
| Mark Meltz Other companies: Lyell Immunopharma, Inc. (General Counsel and Corporate Secretary · Since at least Jun 9, 2025); Audentes Therapeutics Inc (SVP, General Counsel · Mar 28, 2019 – Jan 15, 2020 · Past) | COO GENERAL COUNSEL SECRETARY · Dec 2, 2020 – Apr 3, 2024 · Past |
| Nima Farzan Other companies: Latigo Biotherapeutics, Inc. (President and CEO, Director · Since at least Aug 6, 2026); Keros Therapeutics, Inc. (Director · Since at least May 30, 2024) | CHIEF EXECUTIVE OFFICER, Director · Apr 3, 2024 – Apr 3, 2024 · Past |
| Helen Sabzevari Other companies: Precigen, Inc. (President and CEO · Since at least Nov 27, 2017) | Director · Jun 24, 2021 – Apr 3, 2024 · Past |
| Eric Anthony Murphy | Chief Scientific Officer · Dec 2, 2020 – Feb 12, 2021 · Past |
| Keith T Flaherty | Director · Apr 3, 2024 – Apr 3, 2024 · Past |
| Richard Thomas Williams | CHIEF MEDICAL OFFICER · Dec 2, 2020 – Mar 1, 2024 · Past |
Log in to ask 6ix AI your own questions about Kinnate Biopharma Inc.